In the last 12 months, insiders at IOVANCE BIOTHERAPEUTICS, INC. ($IOVA) filed 315 transactions with the SEC: 8 open-market purchases totaling $74,993,093 and 1 sales totaling $503,000. Net insider sentiment: net buying.
IOVANCE BIOTHERAPEUTICS, INC. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Rothbaum Wayne P. (Director) — 3 transactions totaling $72,250,000
- MCPEAK MERRILL A (Director) — 4 transactions totaling $2,343,100
- Vogt Frederick G (Interim CEO & General Counsel) — 72 transactions totaling $2,074,839
- Maynard Ryan D (Director) — 7 transactions totaling $875,500
- GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) — 76 transactions totaling $786,131
View all SEC Filings for IOVANCE BIOTHERAPEUTICS, INC. (IOVA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | A | Restricted Stock Units | 58750 | $0.00 | 58,750.0000 | 357,345 | 9999.99% | 16.44% |
| March 9, 2026 | Kirby Daniel Gordon | Chief Commercial Officer | A | Restricted Stock Units | 132200 | $0.00 | 132,200.0000 | 357,345 | 9999.99% | 37.00% |
| March 9, 2026 | BILINSKY IGOR | Chief Operating Officer | A | Restricted Stock Units | 117500 | $0.00 | 117,500.0000 | 357,345 | 9999.99% | 32.88% |
| March 9, 2026 | Roche Corleen M. | Chief Financial Officer | A | Restricted Stock Units | 132200 | $0.00 | 132,200.0000 | 357,345 | 9999.99% | 37.00% |
| March 9, 2026 | Vogt Frederick G | Interim CEO & General Counsel | A | Restricted Stock Units | 235000 | $0.00 | 235,000.0000 | 357,345 | 9999.99% | 65.76% |
| March 9, 2026 | Puri Raj K. | Chief Regulatory Officer | A | Restricted Stock Units | 117500 | $0.00 | 117,500.0000 | 357,345 | 9999.99% | 32.88% |
| March 5, 2026 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 31246 | $0.00 | 142,394.0000 | 357,345 | 28.11% | 8.74% |
| March 5, 2026 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 16628 | $4.58 | 125,766.0000 | 357,345 | 11.68% | 4.65% |
| March 5, 2026 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 31246 | $0.00 | 62,504.0000 | 357,345 | 33.33% | 8.74% |
| March 5, 2026 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 62493 | $0.00 | 556,293.0000 | 357,345 | 12.66% | 17.49% |
| March 5, 2026 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 26755 | $4.58 | 529,538.0000 | 357,345 | 4.81% | 7.49% |
| March 5, 2026 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 62493 | $0.00 | 125,007.0000 | 357,345 | 33.33% | 17.49% |
| March 5, 2026 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 31246 | $0.00 | 148,477.0000 | 357,345 | 26.65% | 8.74% |
| March 5, 2026 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 16520 | $4.58 | 131,957.0000 | 357,345 | 11.13% | 4.62% |
| March 5, 2026 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 31246 | $0.00 | 62,504.0000 | 357,345 | 33.33% | 8.74% |
| March 5, 2026 | Puri Raj K. | Chief Regulatory Officer | M | Common Stock | 39059 | $0.00 | 257,590.0000 | 357,345 | 17.87% | 10.93% |
| March 5, 2026 | Puri Raj K. | Chief Regulatory Officer | F | Common Stock | 18360 | $4.58 | 239,230.0000 | 357,345 | 7.13% | 5.14% |
| March 5, 2026 | Puri Raj K. | Chief Regulatory Officer | M | Restricted Stock Units | 39059 | $0.00 | 78,131.0000 | 357,345 | 33.33% | 10.93% |
| March 2, 2026 | Puri Raj K. | Chief Regulatory Officer | F | Common Stock | 2798 | $3.79 | 218,531.0000 | 357,345 | 1.26% | 0.78% |
| March 2, 2026 | Puri Raj K. | Chief Regulatory Officer | M | Restricted Stock Units | 5470 | $0.00 | 21,878.0000 | 357,345 | 20.00% | 1.53% |
| March 2, 2026 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 12697 | $0.00 | 124,353.0000 | 357,345 | 11.37% | 3.55% |
| March 2, 2026 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 7122 | $3.79 | 117,231.0000 | 357,345 | 5.73% | 1.99% |
| March 2, 2026 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 8790 | $0.00 | 35,159.0000 | 357,345 | 20.00% | 2.46% |
| March 2, 2026 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 3907 | $0.00 | 0.0000 | 357,345 | 100.00% | 1.09% |
| March 2, 2026 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 52087 | $0.00 | 516,609.0000 | 357,345 | 11.21% | 14.58% |
| March 2, 2026 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 22809 | $3.79 | 493,800.0000 | 357,345 | 4.42% | 6.38% |
| March 2, 2026 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 41669 | $0.00 | 166,675.0000 | 357,345 | 20.00% | 11.66% |
| March 2, 2026 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 10418 | $0.00 | 0.0000 | 357,345 | 100.00% | 2.92% |
| March 2, 2026 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 12307 | $0.00 | 118,051.0000 | 357,345 | 11.64% | 3.44% |
| March 2, 2026 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 6903 | $3.79 | 111,148.0000 | 357,345 | 5.85% | 1.93% |
| March 2, 2026 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 8790 | $0.00 | 35,159.0000 | 357,345 | 20.00% | 2.46% |
| March 2, 2026 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 3517 | $0.00 | 0.0000 | 357,345 | 100.00% | 0.98% |
| March 2, 2026 | Puri Raj K. | Chief Regulatory Officer | M | Common Stock | 5470 | $0.00 | 221,329.0000 | 357,345 | 2.53% | 1.53% |
| Feb. 24, 2026 | Kirby Daniel Gordon | Chief Commercial Officer | M | Common Stock | 120000 | $0.00 | 173,546.0000 | 357,345 | 224.11% | 33.58% |
| Feb. 24, 2026 | Kirby Daniel Gordon | Chief Commercial Officer | F | Common Stock | 34165 | $3.78 | 139,381.0000 | 357,345 | 19.69% | 9.56% |
| Feb. 24, 2026 | Kirby Daniel Gordon | Chief Commercial Officer | M | Restricted Stock Units | 150000 | $0.00 | 0.0000 | 357,345 | 100.00% | 41.98% |
| Feb. 10, 2026 | Kirby Daniel Gordon | Chief Commercial Officer | M | Common Stock | 39996 | $0.00 | 69,996.0000 | 357,345 | 133.32% | 11.19% |
| Feb. 10, 2026 | Kirby Daniel Gordon | Chief Commercial Officer | F | Common Stock | 16450 | $2.60 | 53,546.0000 | 357,345 | 23.50% | 4.60% |
| Feb. 10, 2026 | Kirby Daniel Gordon | Chief Commercial Officer | M | Restricted Stock Units | 39996 | $0.00 | 80,004.0000 | 357,345 | 33.33% | 11.19% |
| Dec. 2, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1984 | $2.14 | 111,656.0000 | 334,511 | 1.75% | 0.59% |
| Dec. 1, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 4464 | $2.23 | 109,734.0000 | 334,511 | 3.91% | 1.33% |
| Dec. 1, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 8789 | $0.00 | 114,198.0000 | 334,511 | 8.34% | 2.63% |
| Dec. 1, 2025 | Puri Raj K. | Chief Regulatory Officer | M | Restricted Stock Units | 5469 | $0.00 | 27,348.0000 | 334,511 | 16.67% | 1.63% |
| Dec. 1, 2025 | Puri Raj K. | Chief Regulatory Officer | F | Common Stock | 2467 | $2.23 | 215,859.0000 | 334,511 | 1.13% | 0.74% |
| Dec. 1, 2025 | Puri Raj K. | Chief Regulatory Officer | M | Common Stock | 5469 | $0.00 | 218,326.0000 | 334,511 | 2.57% | 1.63% |
| Dec. 2, 2025 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 10417 | $0.00 | 10,418.0000 | 334,511 | 50.00% | 3.11% |
| Dec. 1, 2025 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 41669 | $0.00 | 208,344.0000 | 334,511 | 16.67% | 12.46% |
| Dec. 2, 2025 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 4426 | $2.14 | 464,522.0000 | 334,511 | 0.94% | 1.32% |
| Dec. 2, 2025 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 10417 | $0.00 | 468,948.0000 | 334,511 | 2.27% | 3.11% |
| Dec. 1, 2025 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 17701 | $2.23 | 458,531.0000 | 334,511 | 3.72% | 5.29% |
| Dec. 1, 2025 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 41669 | $0.00 | 476,232.0000 | 334,511 | 9.59% | 12.46% |
| Dec. 2, 2025 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 3516 | $0.00 | 3,517.0000 | 334,511 | 49.99% | 1.05% |
| Dec. 1, 2025 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 8789 | $0.00 | 43,949.0000 | 334,511 | 16.67% | 2.63% |
| Dec. 2, 2025 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1786 | $2.14 | 105,744.0000 | 334,511 | 1.66% | 0.53% |
| Dec. 2, 2025 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 3516 | $0.00 | 107,530.0000 | 334,511 | 3.38% | 1.05% |
| Dec. 1, 2025 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 4464 | $2.23 | 104,014.0000 | 334,511 | 4.12% | 1.33% |
| Dec. 1, 2025 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 8789 | $0.00 | 108,478.0000 | 334,511 | 8.82% | 2.63% |
| Dec. 2, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 3906 | $0.00 | 3,907.0000 | 334,511 | 49.99% | 1.17% |
| Dec. 1, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 8789 | $0.00 | 43,949.0000 | 334,511 | 16.67% | 2.63% |
| Dec. 2, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 3906 | $0.00 | 113,640.0000 | 334,511 | 3.56% | 1.17% |
| Sept. 2, 2025 | Puri Raj K. | Chief Regulatory Officer | F | Common Stock | 2467 | $2.19 | 212,857.0000 | 334,511 | 1.15% | 0.74% |
| Sept. 2, 2025 | Puri Raj K. | Chief Regulatory Officer | M | Restricted Stock Units | 5470 | $0.00 | 32,817.0000 | 334,511 | 14.29% | 1.64% |
| Sept. 2, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 12697 | $0.00 | 111,857.0000 | 334,511 | 12.80% | 3.80% |
| Sept. 2, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 6448 | $2.19 | 105,409.0000 | 334,511 | 5.76% | 1.93% |
| Sept. 2, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 3907 | $0.00 | 7,813.0000 | 334,511 | 33.34% | 1.17% |
| Sept. 2, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 8790 | $0.00 | 52,738.0000 | 334,511 | 14.29% | 2.63% |
| Sept. 2, 2025 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 12306 | $0.00 | 105,939.0000 | 334,511 | 13.14% | 3.68% |
| Sept. 2, 2025 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 6250 | $2.19 | 99,689.0000 | 334,511 | 5.90% | 1.87% |
| Sept. 2, 2025 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 3516 | $0.00 | 7,033.0000 | 334,511 | 33.33% | 1.05% |
| Sept. 2, 2025 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 8790 | $0.00 | 52,738.0000 | 334,511 | 14.29% | 2.63% |
| Sept. 2, 2025 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 52086 | $0.00 | 456,690.0000 | 334,511 | 12.87% | 15.57% |
| Sept. 2, 2025 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 22127 | $2.19 | 434,563.0000 | 334,511 | 4.85% | 6.61% |
| Sept. 2, 2025 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 10417 | $0.00 | 20,385.0000 | 334,511 | 33.82% | 3.11% |
| Sept. 2, 2025 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 41669 | $0.00 | 250,013.0000 | 334,511 | 14.29% | 12.46% |
| Sept. 2, 2025 | Puri Raj K. | Chief Regulatory Officer | M | Common Stock | 5470 | $0.00 | 215,324.0000 | 334,511 | 2.61% | 1.64% |
| Aug. 6, 2025 | Roche Corleen M. | Chief Financial Officer | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 334,511 | 9999.99% | 89.68% |
| Aug. 6, 2025 | Roche Corleen M. | Chief Financial Officer | A | Restricted Stock Units | 150000 | $0.00 | 150,000.0000 | 334,511 | 9999.99% | 44.84% |
| June 13, 2025 | Countouriotis Athena | Director | A | Deferred Restricted Stock Unit | 67546 | $0.00 | 67,546.0000 | 322,868 | 9999.99% | 20.92% |
| June 13, 2025 | Maynard Ryan D | Director | A | Deferred Restricted Stock Unit | 67546 | $0.00 | 67,546.0000 | 322,868 | 9999.99% | 20.92% |
| June 13, 2025 | WEISER MICHAEL | Director | A | Deferred Restricted Stock Unit | 67546 | $0.00 | 67,546.0000 | 322,868 | 9999.99% | 20.92% |
| June 13, 2025 | YARNO WENDY L | Director | A | Deferred Restricted Stock Unit | 67546 | $0.00 | 67,546.0000 | 322,868 | 9999.99% | 20.92% |
| June 13, 2025 | Dukes Iain D. | Director | A | Deferred Restricted Stock Unit | 135092 | $0.00 | 135,092.0000 | 322,868 | 9999.99% | 41.84% |
| June 5, 2025 | Kirby Daniel Gordon | Chief Commercial Officer | P | Common Stock | 30000 | $1.84 | 30,000.0000 | 322,868 | 9999.99% | 9.29% |
| June 2, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 3906 | $0.00 | 11,720.0000 | 322,868 | 25.00% | 1.21% |
| June 2, 2025 | Bellemin Jean-Marc | Chief Financial Officer | M | Restricted Stock Units | 8789 | $0.00 | 61,528.0000 | 322,868 | 12.50% | 2.72% |
| June 2, 2025 | Bellemin Jean-Marc | Chief Financial Officer | F | Common Stock | 4464 | $1.76 | 60,529.0000 | 322,868 | 6.87% | 1.38% |
| June 2, 2025 | Bellemin Jean-Marc | Chief Financial Officer | M | Common Stock | 8789 | $0.00 | 64,993.0000 | 322,868 | 15.64% | 2.72% |
| June 2, 2025 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 8789 | $0.00 | 61,528.0000 | 322,868 | 12.50% | 2.72% |
| June 2, 2025 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 3516 | $0.00 | 10,549.0000 | 322,868 | 25.00% | 1.09% |
| June 2, 2025 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 6250 | $1.76 | 93,633.0000 | 322,868 | 6.26% | 1.94% |
| June 2, 2025 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 12305 | $0.00 | 99,883.0000 | 322,868 | 14.05% | 3.81% |
| June 2, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 8789 | $0.00 | 61,528.0000 | 322,868 | 12.50% | 2.72% |
| June 2, 2025 | Puri Raj K. | Chief Regulatory Officer | M | Common Stock | 5469 | $0.00 | 212,321.0000 | 322,868 | 2.64% | 1.69% |
| June 2, 2025 | Puri Raj K. | Chief Regulatory Officer | F | Common Stock | 2467 | $1.76 | 209,854.0000 | 322,868 | 1.16% | 0.76% |
| June 2, 2025 | Puri Raj K. | Chief Regulatory Officer | M | Restricted Stock Units | 5469 | $0.00 | 38,287.0000 | 322,868 | 12.50% | 1.69% |
| June 2, 2025 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 52085 | $0.00 | 426,731.0000 | 322,868 | 13.90% | 16.13% |
| June 2, 2025 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 22127 | $1.76 | 404,604.0000 | 322,868 | 5.19% | 6.85% |
| June 2, 2025 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 10417 | $0.00 | 31,252.0000 | 322,868 | 25.00% | 3.23% |
| June 2, 2025 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 41668 | $0.00 | 291,682.0000 | 322,868 | 12.50% | 12.91% |
| June 2, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 12695 | $0.00 | 105,608.0000 | 322,868 | 13.66% | 3.93% |
| June 2, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 6448 | $1.76 | 99,160.0000 | 322,868 | 6.11% | 2.00% |
| May 23, 2025 | Puri Raj K. | Chief Regulatory Officer | P | Common Stock | 5600 | $1.74 | 206,852.0000 | 322,868 | 2.78% | 1.73% |
| May 14, 2025 | Vogt Frederick G | Interim CEO & General Counsel | P | Common Stock | 25000 | $1.69 | 374,646.0000 | 322,868 | 7.15% | 7.74% |
| March 14, 2025 | Puri Raj K. | Chief Regulatory Officer | M | Common Stock | 8334 | $0.00 | 203,761.0000 | 289,877 | 4.26% | 2.88% |
| March 14, 2025 | Puri Raj K. | Chief Regulatory Officer | F | Common Stock | 2509 | $3.59 | 201,252.0000 | 289,877 | 1.23% | 0.87% |
| March 14, 2025 | Puri Raj K. | Chief Regulatory Officer | M | Restricted Stock Units | 8334 | $0.00 | 0.0000 | 289,877 | 100.00% | 2.88% |
| March 5, 2025 | Vogt Frederick G | Interim CEO & General Counsel | A | Restricted Stock Units | 187500 | $0.00 | 187,500.0000 | 289,877 | 9999.99% | 64.68% |
| March 5, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | A | Restricted Stock Units | 93750 | $0.00 | 93,750.0000 | 289,877 | 9999.99% | 32.34% |
| March 5, 2025 | BILINSKY IGOR | Chief Operating Officer | A | Restricted Stock Units | 93750 | $0.00 | 93,750.0000 | 289,877 | 9999.99% | 32.34% |
| March 5, 2025 | Bellemin Jean-Marc | Chief Financial Officer | A | Restricted Stock Units | 93750 | $0.00 | 93,750.0000 | 289,877 | 9999.99% | 32.34% |
| March 5, 2025 | Puri Raj K. | Chief Regulatory Officer | A | Restricted Stock Units | 117190 | $0.00 | 117,190.0000 | 289,877 | 9999.99% | 40.43% |
| March 3, 2025 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 62106 | $0.00 | 120,880.0000 | 289,877 | 105.67% | 21.43% |
| March 3, 2025 | Bellemin Jean-Marc | Chief Financial Officer | M | Common Stock | 58590 | $0.00 | 87,938.0000 | 289,877 | 199.64% | 20.21% |
| March 3, 2025 | Bellemin Jean-Marc | Chief Financial Officer | F | Common Stock | 31734 | $4.04 | 56,204.0000 | 289,877 | 36.09% | 10.95% |
| March 3, 2025 | Bellemin Jean-Marc | Chief Financial Officer | M | Restricted Stock Units | 58590 | $0.00 | 70,317.0000 | 289,877 | 45.45% | 20.21% |
| March 3, 2025 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 33302 | $4.04 | 87,578.0000 | 289,877 | 27.55% | 11.49% |
| March 3, 2025 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 3516 | $0.00 | 14,065.0000 | 289,877 | 20.00% | 1.21% |
| March 3, 2025 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 58590 | $0.00 | 70,317.0000 | 289,877 | 45.45% | 20.21% |
| March 3, 2025 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 223943 | $0.00 | 445,059.0000 | 289,877 | 101.28% | 77.25% |
| March 3, 2025 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 95413 | $4.04 | 349,646.0000 | 289,877 | 21.44% | 32.92% |
| March 3, 2025 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 10418 | $0.00 | 41,669.0000 | 289,877 | 20.00% | 3.59% |
| March 3, 2025 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 213525 | $0.00 | 333,350.0000 | 289,877 | 39.04% | 73.66% |
| March 3, 2025 | Puri Raj K. | Chief Regulatory Officer | M | Common Stock | 59999 | $0.00 | 215,411.0000 | 289,877 | 38.61% | 20.70% |
| March 3, 2025 | Puri Raj K. | Chief Regulatory Officer | F | Common Stock | 19984 | $4.04 | 195,427.0000 | 289,877 | 9.28% | 6.89% |
| March 3, 2025 | Puri Raj K. | Chief Regulatory Officer | M | Restricted Stock Units | 59999 | $0.00 | 43,756.0000 | 289,877 | 57.83% | 20.70% |
| March 3, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 62497 | $0.00 | 126,383.0000 | 289,877 | 97.83% | 21.56% |
| March 3, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 33470 | $4.04 | 92,913.0000 | 289,877 | 26.48% | 11.55% |
| March 3, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 3907 | $0.00 | 15,626.0000 | 289,877 | 20.00% | 1.35% |
| March 3, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 58590 | $0.00 | 70,317.0000 | 289,877 | 45.45% | 20.21% |
| Feb. 10, 2025 | Kirby Daniel Gordon | Chief Commercial Officer | A | Performance Stock Units | 150000 | $0.00 | 150,000.0000 | 289,877 | 9999.99% | 51.75% |
| Feb. 10, 2025 | Kirby Daniel Gordon | Chief Commercial Officer | A | Restricted Stock Units | 120000 | $0.00 | 120,000.0000 | 289,877 | 9999.99% | 41.40% |
| Feb. 10, 2025 | Kirby Daniel Gordon | Chief Commercial Officer | A | Stock Options (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 289,877 | 9999.99% | 12.07% |
| Jan. 14, 2025 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 20835 | $0.00 | 231,071.0000 | 289,877 | 9.91% | 7.19% |
| Jan. 14, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1578 | $5.89 | 63,886.0000 | 289,877 | 2.41% | 0.54% |
| Jan. 14, 2025 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 20835 | $0.00 | 0.0000 | 289,877 | 100.00% | 7.19% |
| Jan. 14, 2025 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 9955 | $5.89 | 221,116.0000 | 289,877 | 4.31% | 3.43% |
| Jan. 14, 2025 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 2813 | $0.00 | 60,352.0000 | 289,877 | 4.89% | 0.97% |
| Jan. 14, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 2813 | $0.00 | 0.0000 | 289,877 | 100.00% | 0.97% |
| Jan. 14, 2025 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 2813 | $0.00 | 65,464.0000 | 289,877 | 4.49% | 0.97% |
| Jan. 14, 2025 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 2813 | $0.00 | 0.0000 | 289,877 | 100.00% | 0.97% |
| Jan. 14, 2025 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1578 | $5.89 | 58,774.0000 | 289,877 | 2.61% | 0.54% |
| Dec. 16, 2024 | Puri Raj K. | Chief Regulatory Officer | F | Common Stock | 3759 | $7.84 | 155,412.0000 | 303,269 | 2.36% | 1.24% |
| Dec. 16, 2024 | Puri Raj K. | Chief Regulatory Officer | M | Common Stock | 8334 | $0.00 | 159,171.0000 | 303,269 | 5.53% | 2.75% |
| Dec. 16, 2024 | Puri Raj K. | Chief Regulatory Officer | M | Restricted Stock Units | 8334 | $0.00 | 8,334.0000 | 303,269 | 50.00% | 2.75% |
| Dec. 2, 2024 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 4426 | $9.07 | 210,236.0000 | 303,269 | 2.06% | 1.46% |
| Dec. 2, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 3516 | $0.00 | 59,323.0000 | 303,269 | 6.30% | 1.16% |
| Dec. 2, 2024 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1784 | $9.07 | 57,539.0000 | 303,269 | 3.01% | 0.59% |
| Dec. 2, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 3516 | $0.00 | 17,581.0000 | 303,269 | 16.67% | 1.16% |
| Dec. 2, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 3906 | $0.00 | 64,633.0000 | 303,269 | 6.43% | 1.29% |
| Dec. 2, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 3906 | $0.00 | 19,533.0000 | 303,269 | 16.66% | 1.29% |
| Dec. 2, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 10417 | $0.00 | 214,662.0000 | 303,269 | 5.10% | 3.43% |
| Dec. 2, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 10417 | $0.00 | 52,087.0000 | 303,269 | 16.67% | 3.43% |
| Dec. 2, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1982 | $9.07 | 62,651.0000 | 303,269 | 3.07% | 0.65% |
| Nov. 12, 2024 | Maynard Ryan D | Director | M | Common Stock | 50000 | $7.45 | 57,500.0000 | 303,269 | 666.67% | 16.49% |
| Nov. 12, 2024 | Maynard Ryan D | Director | S | Common Stock | 50000 | $10.06 | 7,500.0000 | 303,269 | 86.96% | 16.49% |
| Nov. 12, 2024 | Maynard Ryan D | Director | M | Stock Option (right to buy) | 50000 | $0.00 | 0.0000 | 303,269 | 100.00% | 16.49% |
| Oct. 14, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1428 | $9.77 | 60,727.0000 | 303,269 | 2.30% | 0.47% |
| Oct. 14, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 2813 | $0.00 | 2,813.0000 | 303,269 | 50.00% | 0.93% |
| Oct. 14, 2024 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1428 | $9.77 | 55,807.0000 | 303,269 | 2.49% | 0.47% |
| Oct. 14, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 2813 | $0.00 | 57,235.0000 | 303,269 | 5.17% | 0.93% |
| Oct. 14, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 2813 | $0.00 | 2,813.0000 | 303,269 | 50.00% | 0.93% |
| Oct. 14, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 2813 | $0.00 | 62,155.0000 | 303,269 | 4.74% | 0.93% |
| Oct. 14, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 20834 | $0.00 | 20,835.0000 | 303,269 | 50.00% | 6.87% |
| Oct. 14, 2024 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 8851 | $9.77 | 204,245.0000 | 303,269 | 4.15% | 2.92% |
| Oct. 14, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 20834 | $0.00 | 213,096.0000 | 303,269 | 10.84% | 6.87% |
| Sept. 3, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 10417 | $0.00 | 169,726.0000 | 284,817 | 6.54% | 3.66% |
| Sept. 3, 2024 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 4426 | $10.85 | 165,300.0000 | 284,817 | 2.61% | 1.55% |
| Sept. 3, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 46875 | $0.00 | 212,175.0000 | 284,817 | 28.36% | 16.46% |
| Sept. 3, 2024 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 19913 | $10.85 | 192,262.0000 | 284,817 | 9.39% | 6.99% |
| Sept. 3, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 10417 | $0.00 | 62,504.0000 | 284,817 | 14.29% | 3.66% |
| Sept. 3, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 46875 | $0.00 | 46,875.0000 | 284,817 | 50.00% | 16.46% |
| Sept. 3, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 3907 | $0.00 | 49,778.0000 | 284,817 | 8.52% | 1.37% |
| Sept. 3, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1983 | $10.85 | 47,795.0000 | 284,817 | 3.98% | 0.70% |
| Sept. 3, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 23438 | $0.00 | 71,233.0000 | 284,817 | 49.04% | 8.23% |
| Sept. 3, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 3516 | $0.00 | 44,659.0000 | 284,817 | 8.55% | 1.23% |
| Sept. 3, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 23438 | $0.00 | 23,437.0000 | 284,817 | 50.00% | 8.23% |
| Sept. 3, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 3907 | $0.00 | 23,439.0000 | 284,817 | 14.29% | 1.37% |
| Sept. 3, 2024 | Bellemin Jean-Marc | Chief Financial Officer | M | Restricted Stock Units | 23438 | $0.00 | 23,437.0000 | 284,817 | 50.00% | 8.23% |
| Sept. 3, 2024 | Bellemin Jean-Marc | Chief Financial Officer | F | Common Stock | 11891 | $10.85 | 29,348.0000 | 284,817 | 28.83% | 4.18% |
| Sept. 3, 2024 | Bellemin Jean-Marc | Chief Financial Officer | M | Common Stock | 23438 | $0.00 | 41,239.0000 | 284,817 | 131.67% | 8.23% |
| Sept. 3, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 23438 | $0.00 | 23,437.0000 | 284,817 | 50.00% | 8.23% |
| Sept. 3, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 3516 | $0.00 | 21,097.0000 | 284,817 | 14.29% | 1.23% |
| Sept. 3, 2024 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 11891 | $10.85 | 54,422.0000 | 284,817 | 17.93% | 4.18% |
| Sept. 3, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 11891 | $10.85 | 59,342.0000 | 284,817 | 16.69% | 4.18% |
| Sept. 3, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 23438 | $0.00 | 66,313.0000 | 284,817 | 54.67% | 8.23% |
| Sept. 3, 2024 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1784 | $10.85 | 42,875.0000 | 284,817 | 3.99% | 0.63% |
| July 15, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 2813 | $0.00 | 42,571.0000 | 284,817 | 7.08% | 0.99% |
| July 15, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 20835 | $0.00 | 168,160.0000 | 284,817 | 14.14% | 7.32% |
| July 15, 2024 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 8851 | $8.68 | 159,309.0000 | 284,817 | 5.26% | 3.11% |
| July 15, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 20835 | $0.00 | 41,669.0000 | 284,817 | 33.33% | 7.32% |
| July 15, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 2813 | $0.00 | 5,626.0000 | 284,817 | 33.33% | 0.99% |
| July 15, 2024 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1428 | $8.68 | 41,143.0000 | 284,817 | 3.35% | 0.50% |
| July 15, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 2813 | $0.00 | 5,626.0000 | 284,817 | 33.33% | 0.99% |
| July 15, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1428 | $8.68 | 45,871.0000 | 284,817 | 3.02% | 0.50% |
| July 15, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 2813 | $0.00 | 47,299.0000 | 284,817 | 6.32% | 0.99% |
| June 11, 2024 | Countouriotis Athena | Director | A | Deferred Restricted Stock Unit | 49303 | $0.00 | 49,303.0000 | 266,220 | 9999.99% | 18.52% |
| June 11, 2024 | YARNO WENDY L | Director | A | Deferred Restricted Stock Unit | 49303 | $0.00 | 49,303.0000 | 266,220 | 9999.99% | 18.52% |
| June 11, 2024 | WEISER MICHAEL | Director | A | Deferred Restricted Stock Unit | 49303 | $0.00 | 49,303.0000 | 266,220 | 9999.99% | 18.52% |
| June 11, 2024 | Maynard Ryan D | Director | A | Deferred Restricted Stock Unit | 49303 | $0.00 | 49,303.0000 | 266,220 | 9999.99% | 18.52% |
| June 11, 2024 | Dukes Iain D. | Director | A | Deferred Restricted Stock Unit | 98607 | $0.00 | 98,607.0000 | 266,220 | 9999.99% | 37.04% |
| June 3, 2024 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 4426 | $8.37 | 147,325.0000 | 266,220 | 2.92% | 1.66% |
| June 3, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 3906 | $0.00 | 46,468.0000 | 266,220 | 9.18% | 1.47% |
| June 3, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 3516 | $0.00 | 24,613.0000 | 266,220 | 12.50% | 1.32% |
| June 3, 2024 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1784 | $8.37 | 39,758.0000 | 266,220 | 4.29% | 0.67% |
| June 3, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 10417 | $0.00 | 151,751.0000 | 266,220 | 7.37% | 3.91% |
| June 3, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1982 | $8.37 | 44,486.0000 | 266,220 | 4.27% | 0.74% |
| June 3, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 3906 | $0.00 | 27,346.0000 | 266,220 | 12.50% | 1.47% |
| June 3, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 3516 | $0.00 | 41,542.0000 | 266,220 | 9.25% | 1.32% |
| June 3, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 10417 | $0.00 | 72,921.0000 | 266,220 | 12.50% | 3.91% |
| April 15, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 20834 | $0.00 | 62,504.0000 | 266,220 | 25.00% | 7.83% |
| April 15, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 2812 | $0.00 | 8,439.0000 | 266,220 | 24.99% | 1.06% |
| April 15, 2024 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1427 | $11.89 | 38,026.0000 | 266,220 | 3.62% | 0.54% |
| April 15, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 2812 | $0.00 | 39,453.0000 | 266,220 | 7.67% | 1.06% |
| April 15, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 2812 | $0.00 | 8,439.0000 | 266,220 | 24.99% | 1.06% |
| April 15, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1427 | $11.89 | 42,562.0000 | 266,220 | 3.24% | 0.54% |
| April 15, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 2812 | $0.00 | 43,989.0000 | 266,220 | 6.83% | 1.06% |
| April 15, 2024 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 8851 | $11.89 | 141,334.0000 | 266,220 | 5.89% | 3.32% |
| April 15, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 20834 | $0.00 | 150,185.0000 | 266,220 | 16.11% | 7.83% |
| March 4, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 15623 | $0.00 | 49,230.0000 | 235,131 | 46.49% | 6.64% |
| March 4, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 14061 | $0.00 | 28,129.0000 | 235,131 | 33.33% | 5.98% |
| March 4, 2024 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 7287 | $16.96 | 36,641.0000 | 235,131 | 16.59% | 3.10% |
| March 4, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 14061 | $0.00 | 43,928.0000 | 235,131 | 47.08% | 5.98% |
| March 4, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 41662 | $0.00 | 83,338.0000 | 235,131 | 33.33% | 17.72% |
| March 4, 2024 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 11449 | $16.96 | 129,351.0000 | 235,131 | 8.13% | 4.87% |
| March 4, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 41662 | $0.00 | 140,800.0000 | 235,131 | 42.02% | 17.72% |
| March 4, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 15623 | $0.00 | 31,252.0000 | 235,131 | 33.33% | 6.64% |
| March 4, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 8053 | $16.96 | 41,177.0000 | 235,131 | 16.36% | 3.42% |
| March 1, 2024 | YARNO WENDY L | Director | A | Deferred Restricted Stock Unit | 25000 | $0.00 | 25,000.0000 | 235,131 | 9999.99% | 10.63% |
| March 1, 2024 | Rothbaum Wayne P. | Director | A | Deferred Restricted Stock Unit | 100000 | $0.00 | 100,000.0000 | 235,131 | 9999.99% | 42.53% |
| March 1, 2024 | Vogt Frederick G | Interim CEO & General Counsel | A | Restricted Stock Units | 500000 | $0.00 | 500,000.0000 | 235,131 | 9999.99% | 100.00% |
| March 1, 2024 | Vogt Frederick G | Interim CEO & General Counsel | A | Restricted Stock Units | 93750 | $0.00 | 93,750.0000 | 235,131 | 9999.99% | 39.87% |
| March 1, 2024 | Maynard Ryan D | Director | A | Deferred Restricted Stock Unit | 50000 | $0.00 | 50,000.0000 | 235,131 | 9999.99% | 21.27% |
| March 1, 2024 | WEISER MICHAEL | Director | A | Deferred Restricted Stock Unit | 100000 | $0.00 | 100,000.0000 | 235,131 | 9999.99% | 42.53% |
| March 1, 2024 | MCPEAK MERRILL A | Director | A | Deferred Restricted Stock Unit | 50000 | $0.00 | 50,000.0000 | 235,131 | 9999.99% | 21.27% |
| March 1, 2024 | Dukes Iain D. | Director | A | Deferred Restricted Stock Unit | 100000 | $0.00 | 100,000.0000 | 235,131 | 9999.99% | 42.53% |
| March 1, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | A | Restricted Stock Units | 105470 | $0.00 | 105,470.0000 | 235,131 | 9999.99% | 44.86% |
| March 1, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | A | Restricted Stock Units | 46875 | $0.00 | 46,875.0000 | 235,131 | 9999.99% | 19.94% |
| March 1, 2024 | BILINSKY IGOR | Chief Operating Officer | A | Restricted Stock Units | 105470 | $0.00 | 105,470.0000 | 235,131 | 9999.99% | 44.86% |
| March 1, 2024 | BILINSKY IGOR | Chief Operating Officer | A | Restricted Stock Units | 46875 | $0.00 | 46,875.0000 | 235,131 | 9999.99% | 19.94% |
| March 1, 2024 | Bellemin Jean-Marc | Chief Financial Officer | A | Restricted Stock Units | 105470 | $0.00 | 105,470.0000 | 235,131 | 9999.99% | 44.86% |
| March 1, 2024 | Bellemin Jean-Marc | Chief Financial Officer | A | Restricted Stock Units | 46875 | $0.00 | 46,875.0000 | 235,131 | 9999.99% | 19.94% |
| March 1, 2024 | Countouriotis Athena | Director | A | Deferred Restricted Stock Unit | 50000 | $0.00 | 50,000.0000 | 235,131 | 9999.99% | 21.27% |
| Feb. 20, 2024 | Rothbaum Wayne P. | Director | P | Common Stock | 5000000 | $9.15 | 28,067,333.0000 | 235,131 | 21.68% | 100.00% |
| Feb. 20, 2024 | MCPEAK MERRILL A | Director | P | Common Stock | 250000 | $9.15 | 568,783.0000 | 235,131 | 78.42% | 100.00% |
| Feb. 20, 2024 | Dukes Iain D. | Director | P | Common Stock | 32000 | $9.15 | 54,000.0000 | 235,131 | 145.45% | 13.61% |
| Jan. 16, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 20834 | $0.00 | 83,338.0000 | 235,131 | 20.00% | 8.86% |
| Jan. 16, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 2813 | $0.00 | 35,184.0000 | 235,131 | 8.69% | 1.20% |
| Jan. 16, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1577 | $8.37 | 33,607.0000 | 235,131 | 4.48% | 0.67% |
| Jan. 16, 2024 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 2813 | $0.00 | 11,251.0000 | 235,131 | 20.00% | 1.20% |
| Jan. 16, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 2813 | $0.00 | 31,444.0000 | 235,131 | 9.83% | 1.20% |
| Jan. 16, 2024 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 2813 | $0.00 | 11,251.0000 | 235,131 | 20.00% | 1.20% |
| Jan. 16, 2024 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1577 | $8.37 | 29,867.0000 | 235,131 | 5.02% | 0.67% |
| Jan. 16, 2024 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 20834 | $0.00 | 105,668.0000 | 235,131 | 24.56% | 8.86% |
| Jan. 16, 2024 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 6530 | $8.37 | 99,138.0000 | 235,131 | 6.18% | 2.78% |
| Oct. 16, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1395 | $3.57 | 32,371.0000 | 245,817 | 4.13% | 0.57% |
| Oct. 16, 2023 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 20835 | $0.00 | 93,685.0000 | 245,817 | 28.60% | 8.48% |
| Oct. 16, 2023 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 8851 | $3.57 | 84,834.0000 | 245,817 | 9.45% | 3.60% |
| Oct. 16, 2023 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 20835 | $0.00 | 104,172.0000 | 245,817 | 16.67% | 8.48% |
| Oct. 16, 2023 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 2813 | $0.00 | 30,026.0000 | 245,817 | 10.34% | 1.14% |
| Oct. 16, 2023 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1395 | $3.57 | 28,631.0000 | 245,817 | 4.65% | 0.57% |
| Oct. 16, 2023 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 2813 | $0.00 | 14,064.0000 | 245,817 | 16.67% | 1.14% |
| Oct. 16, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 2813 | $0.00 | 33,766.0000 | 245,817 | 9.09% | 1.14% |
| Oct. 16, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 2813 | $0.00 | 14,064.0000 | 245,817 | 16.67% | 1.14% |
| Sept. 18, 2023 | MCPEAK MERRILL A | Director | P | Common Stock | 10000 | $5.56 | 318,783.0000 | 224,481 | 3.24% | 4.45% |
| Sept. 15, 2023 | Rothbaum Wayne P. | Director | P | Common Stock | 5000000 | $5.30 | 23,067,333.0000 | 224,481 | 27.67% | 100.00% |
| July 14, 2023 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1395 | $7.76 | 27,213.0000 | 224,481 | 4.88% | 0.62% |
| July 14, 2023 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 20834 | $0.00 | 81,701.0000 | 224,481 | 34.23% | 9.28% |
| July 14, 2023 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 8851 | $7.76 | 72,850.0000 | 224,481 | 10.83% | 3.94% |
| July 14, 2023 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 20834 | $0.00 | 125,007.0000 | 224,481 | 14.29% | 9.28% |
| July 14, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 2813 | $0.00 | 32,348.0000 | 224,481 | 9.52% | 1.25% |
| July 14, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1395 | $7.76 | 30,953.0000 | 224,481 | 4.31% | 0.62% |
| July 14, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 2813 | $0.00 | 16,877.0000 | 224,481 | 14.29% | 1.25% |
| July 14, 2023 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 2813 | $0.00 | 28,608.0000 | 224,481 | 10.91% | 1.25% |
| July 14, 2023 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 2813 | $0.00 | 16,877.0000 | 224,481 | 14.29% | 1.25% |
| June 6, 2023 | Dukes Iain D. | Director | A | Deferred Restricted Stock Unit | 103911 | $0.00 | 103,911.0000 | 213,694,000 | 9999.99% | 0.05% |
| June 6, 2023 | YARNO WENDY L | Director | A | Deferred Restricted Stock Unit | 12988 | $0.00 | 12,988.0000 | 213,694,000 | 9999.99% | 0.01% |
| June 6, 2023 | WEISER MICHAEL | Director | A | Deferred Restricted Stock Unit | 51955 | $0.00 | 51,955.0000 | 213,694,000 | 9999.99% | 0.02% |
| June 6, 2023 | Maynard Ryan D | Director | A | Deferred Restricted Stock Unit | 51955 | $0.00 | 51,955.0000 | 213,694,000 | 9999.99% | 0.02% |
| June 6, 2023 | MCPEAK MERRILL A | Director | A | Deferred Restricted Stock Unit | 51955 | $0.00 | 51,955.0000 | 213,694,000 | 9999.99% | 0.02% |
| June 6, 2023 | Countouriotis Athena | Director | A | Deferred Restricted Stock Unit | 51955 | $0.00 | 51,955.0000 | 213,694,000 | 9999.99% | 0.02% |
| April 18, 2023 | YARNO WENDY L | Director | A | Deferred Restricted Stock Unit | 74823 | $0.00 | 74,823.0000 | 213,694,000 | 9999.99% | 0.04% |
| April 14, 2023 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 8851 | $5.64 | 60,867.0000 | 213,694,000 | 12.70% | 0.00% |
| April 14, 2023 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 20834 | $0.00 | 145,841.0000 | 213,694,000 | 12.50% | 0.01% |
| April 14, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 2812 | $0.00 | 30,930.0000 | 213,694,000 | 10.00% | 0.00% |
| April 14, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1395 | $5.64 | 29,535.0000 | 213,694,000 | 4.51% | 0.00% |
| April 14, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 2812 | $0.00 | 19,690.0000 | 213,694,000 | 12.50% | 0.00% |
| April 14, 2023 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 20834 | $0.00 | 69,718.0000 | 213,694,000 | 42.62% | 0.01% |
| April 14, 2023 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 2812 | $0.00 | 27,190.0000 | 213,694,000 | 11.53% | 0.00% |
| April 14, 2023 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 2812 | $0.00 | 19,690.0000 | 213,694,000 | 12.50% | 0.00% |
| April 14, 2023 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 1395 | $5.64 | 25,795.0000 | 213,694,000 | 5.13% | 0.00% |
| March 2, 2023 | BILINSKY IGOR | Chief Operating Officer | A | Stock Option (right to buy) | 84380 | $0.00 | 84,380.0000 | 159,259 | 9999.99% | 52.98% |
| March 2, 2023 | Vogt Frederick G | See Remarks | A | Restricted Stock Units | 125000 | $0.00 | 125,000.0000 | 159,259 | 9999.99% | 78.49% |
| March 2, 2023 | Vogt Frederick G | See Remarks | A | Stock Option (right to buy) | 500000 | $0.00 | 500,000.0000 | 159,259 | 9999.99% | 100.00% |
| March 2, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | A | Restricted Stock Units | 46875 | $0.00 | 46,875.0000 | 159,259 | 9999.99% | 29.43% |
| March 2, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | A | Stock Option (right to buy) | 93750 | $0.00 | 93,750.0000 | 159,259 | 9999.99% | 58.87% |
| March 2, 2023 | BILINSKY IGOR | Chief Operating Officer | A | Restricted Stock Units | 42190 | $0.00 | 42,190.0000 | 159,259 | 9999.99% | 26.49% |
| March 2, 2023 | Bellemin Jean-Marc | Chief Financial Officer | A | Stock Option (right to buy) | 168750 | $0.00 | 168,750.0000 | 159,259 | 9999.99% | 100.00% |
| Jan. 17, 2023 | Vogt Frederick G | Interim CEO & General Counsel | M | Restricted Stock Units | 83325 | $0.00 | 166,675.0000 | 159,259 | 33.33% | 52.32% |
| Jan. 17, 2023 | Vogt Frederick G | Interim CEO & General Counsel | F | Common Stock | 36441 | $6.43 | 48,884.0000 | 159,259 | 42.71% | 22.88% |
| Jan. 17, 2023 | Vogt Frederick G | Interim CEO & General Counsel | M | Common Stock | 83325 | $0.00 | 85,325.0000 | 159,259 | 4166.25% | 52.32% |
| Jan. 17, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 11248 | $0.00 | 32,796.0000 | 159,259 | 52.20% | 7.06% |
| Jan. 17, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 4678 | $6.43 | 28,118.0000 | 159,259 | 14.26% | 2.94% |
| Jan. 17, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 11248 | $0.00 | 22,502.0000 | 159,259 | 33.33% | 7.06% |
| Jan. 17, 2023 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 11248 | $0.00 | 29,049.0000 | 159,259 | 63.19% | 7.06% |
| Jan. 17, 2023 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 4671 | $6.43 | 24,378.0000 | 159,259 | 16.08% | 2.93% |
| Jan. 17, 2023 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 11248 | $0.00 | 22,502.0000 | 159,259 | 33.33% | 7.06% |
| Jan. 3, 2023 | BILINSKY IGOR | Chief Operating Officer | M | Restricted Stock Units | 18850 | $0.00 | 0.0000 | 159,259 | 100.00% | 11.84% |
| Jan. 3, 2023 | BILINSKY IGOR | Chief Operating Officer | F | Common Stock | 10553 | $6.11 | 17,801.0000 | 159,259 | 37.22% | 6.63% |
| Jan. 3, 2023 | BILINSKY IGOR | Chief Operating Officer | M | Common Stock | 18850 | $0.00 | 28,354.0000 | 159,259 | 198.34% | 11.84% |
| Jan. 3, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 19690 | $0.00 | 0.0000 | 159,259 | 100.00% | 12.36% |
| Jan. 3, 2023 | Bellemin Jean-Marc | Chief Financial Officer | F | Common Stock | 10553 | $6.11 | 17,801.0000 | 159,259 | 37.22% | 6.63% |
| Jan. 3, 2023 | Bellemin Jean-Marc | Chief Financial Officer | M | Restricted Stock Units | 18850 | $0.00 | 0.0000 | 159,259 | 100.00% | 11.84% |
| Jan. 3, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 11023 | $6.11 | 21,548.0000 | 159,259 | 33.84% | 6.92% |
| Jan. 3, 2023 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 19690 | $0.00 | 32,571.0000 | 159,259 | 152.86% | 12.36% |
| Jan. 3, 2023 | Bellemin Jean-Marc | Chief Financial Officer | M | Common Stock | 18850 | $0.00 | 28,354.0000 | 159,259 | 198.34% | 11.84% |